↓ Skip to main content

Clazakizumab in late antibody-mediated rejection: study protocol of a randomized controlled pilot trial

Overview of attention for article published in Trials, January 2019
Altmetric Badge

Mentioned by

twitter
14 X users
patent
1 patent

Citations

dimensions_citation
50 Dimensions

Readers on

mendeley
77 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Clazakizumab in late antibody-mediated rejection: study protocol of a randomized controlled pilot trial
Published in
Trials, January 2019
DOI 10.1186/s13063-018-3158-6
Pubmed ID
Authors

Farsad Eskandary, Michael Dürr, Klemens Budde, Konstantin Doberer, Roman Reindl-Schwaighofer, Johannes Waiser, Markus Wahrmann, Heinz Regele, Andreas Spittler, Nils Lachmann, Christa Firbas, Jakob Mühlbacher, Gregor Bond, Philipp F. Halloran, Edward Chong, Bernd Jilma, Georg A. Böhmig

X Demographics

X Demographics

The data shown below were collected from the profiles of 14 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 77 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 77 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 9 12%
Student > Bachelor 9 12%
Researcher 7 9%
Student > Doctoral Student 7 9%
Student > Master 6 8%
Other 10 13%
Unknown 29 38%
Readers by discipline Count As %
Medicine and Dentistry 22 29%
Biochemistry, Genetics and Molecular Biology 8 10%
Immunology and Microbiology 5 6%
Nursing and Health Professions 5 6%
Pharmacology, Toxicology and Pharmaceutical Science 3 4%
Other 6 8%
Unknown 28 36%